Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Diphenoxylate · Diphenoxylate Hydrochloride And Atropine Sulfate, Isopto Atropine

Small molecule · Agonist of opioid receptors · developed by Pfizer

Approved FDA, Sep 1960
1 Registered trials

What is Diphenoxylate?

Diphenoxylate is a piperidine derivative chemically related to meperidine that acts on opioid receptors in the gastrointestinal tract to decrease motility and prevent diarrhea.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Diphenoxylate Hydrochloride And Atropine Sulfate, Isopto Atropine, Lomotil
Drug type
Small molecule
Targets
opioid receptors
Mechanism
Agonist of opioid receptors
Pathways
gastrointestinal motility
Therapy area
Oncology
Developer
Pfizer
In trials of
PBYI
FDA status
Approved as Diphenoxylate Hydrochloride And Atropine Sulfate, Isopto Atropine, Lomotil (September 15, 1960), NDA012462 · FDA label
UNII
73312P173G

✅ FDA-approved uses

From the indications section of the FDA label (version of Feb 23, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03094052 Phase 2 HER2-positive Breast Cancer Completed PBYI

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Breast AdenocarcinomaHER2-positive Breast CancerStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7Stage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.